Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4.
Xiao J, Pan Y, Li XH, Yang XY, Feng YL, Tan HH, Jiang L, Feng J, Yu XY. · 2016
Read Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. by Xiao J, Pan Y, Li XH, Yang XY, Feng YL, Tan HH, Jiang L, Feng J, Yu XY. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5143405.txt.
Introduction
J. Xiao and eight co-authors studied protective vesicles from heart stem cells in Cell Death and Disease in 2016. Cardiac progenitor cells from adult hearts are a promising repair cell type, and their secreted exosomes carry small RNAs between cells. The team asked how those vesicles shield heart muscle under oxidative stress.
Stressed progenitor cells released more exosomes, and one cargo RNA, miR-21, rose sharply in them. In heart cells, miR-21 held down a death-promoting gene called PDCD4; vesicle treatment restored miR-21, lowered PDCD4, and made the cells resist stress-driven death. Blocking pieces of the chain removed the protection, confirming the route. The authors propose progenitor exosomes as a cell-free therapy vehicle for ischemic heart disease.
Catalog record
| CREATOR | Xiao J, Pan Y, Li XH, Yang XY, Feng YL, Tan HH, Jiang L, Feng J, Yu XY. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4 By J Xiao, Y Pan, X H Li, X Y Yang, Y L Feng, H H Tan, L Jiang, J Feng, X Y Yu Published in: Cell Death & Disease DOI: 10.1038/cddis.2016.181 ABSTRACT Cardiac progenitor cells derived from adult heart have emerged as one of the most promising stem cell types for cardiac protection and repair. Exosomes are known to mediate cell–cell communication by transporting cell-derived proteins and nucleic acids, including various microRNAs (miRNAs). Here we investigated the cardiac progenitor cell (CPC)-derived exosomal miRNAs on protecting myocardium under oxidative stress. Sca1+CPCs-derived exosomes were purified from conditional medium, and identified by nanoparticle trafficking analysis (NTA), transmission electron microscopy and western blotting using CD63, CD9 and Alix as markers. Exosomes production was measured by NTA, the result showed that oxidative stress-induced CPCs secrete more exosomes compared with normal condition. Although six apoptosis-related miRNAs could be detected in two different treatment-derived exosomes, only miR-21 was significantly upregulated in oxidative stress-induced exosomes compared with normal exosomes. The same oxidative stress could cause low miR-21 and high cleaved caspase-3 expression in H9C2 cardiac cells. But the cleaved caspase-3 was significantly decreased when miR-21 was overexpressed by transfecting miR-21 mimic. Furthermore, miR-21 mimic or inhibitor transfection and luciferase activity assay confirmed that programmed cell death 4 (PDCD4) was a target gene of miR-21, and miR-21/PDCD4 axis has an important role in anti-apoptotic effect of H9C2 cell. Western blotting and Annexin V/PI results demonstrated that exosomes pre-treated H9C2 exhibited increased miR-21 whereas decreased PDCD4, and had more resistant potential to the apoptosis induced by the oxidative stress, compared with non-treated cells. These findings revealed that CPC-derived exosomal miR-21 had an inhibiting role in the apoptosis pathway through downregulating PDCD4. Restored miR-21/PDCD4 pathway using CPC-derived exosomes could protect myocardial cells against oxidative stress-related apoptosis. Therefore, exosomes could be used as a new therapeutic vehicle for ischemic cardiac disease. Cardiovascular disease is one of the leading pathological causes of mortality worldwide. Cardiovascular ischemic diseases such as heart failure, acute myocardial infarction and myocardial ischemia/reperfusion injury produce plenty of reactive oxygen species (ROS) in ischemic zone,1, 2 which is a major contributor to cardiomyocyte apoptosis and death, and deteriorates cardiac disease. Therefore, it is urgent to find an effective way to restore the cardiovascular system under oxidative stress. Stem cell transplantation is an effective way to replace the apoptotic or dead cardiomyocytes, but the underlying mechanism of this repair process has not been fully explained. Cardiac progenitor cells (CPCs) resident in adult heart have emerged as one of the most promising stem cell types for cardiac regeneration and repair. The mechanism of post transplantation has always been predicated on the hypothesis that these cells would engraft, differentiate and replace damaged cardiac tissues. Although both direct cell differentiation and indirect paracrine effect mechanisms have been implicated in the therapeutic benefit, accumulating evidence suggests predominant roles of the paracrine secretion by CPCs.3 Furthermore, many researchers indicate that transplanted CPCs secrete a lot of factors to reduce tissue injury and/or enhance tissue repair.4, 5 Over the past few years, several experimental evidences have demonstrated that the CPCs released a specialized membranous nano-sized vesicle termed exosomes to improve cardiac function in the damaged heart.5, 6, 7 Exosomes are small (30–100 nm) membrane vesicles, merging their membrane contents into the recipient cell membrane and delivering effectors including transcription factors, oncogenes, small and large non-coding regulatory RNAs (such as microRNAs (miRNAs)), mRNAs and infectious particles into recipient cells.8, 9 In this way, exosomes secreted by CPCs were considered to participate in cardiac protection and repair.7, 10, 11 But exosomes contents vary from different pathological conditions, the difference might cause completely reversed fate of target cells. Hence, it is fruitful to investigate the biological function of exosomes under a specific pathological condition, including oxidative stress. In addition, this study will provide new theoretical basis for treatment of myocardium injury. Among the contents of exosomes, miRNAs have been shown to govern important processes that contribute to the pathophysiological consequences of acute myocardial infarction.12 It is a class of short (about 22 nucleotides), single-stranded non-coding RNAs that have key roles in the regulation of gene expression. miRNAs can either promote or inhibit cardiomyocyte cell apoptosis,13 and also regulate ROS-mediated heart disease.14, 15 But whether miRNAs from CPC-derived exosomes have some important role in ROS-induced cardiomyocytes was still undetermined. Here we investigated the protective effect of the CPC-derived exosomes for myocardial cells in ischemic myocardial injury model, which is mainly through passing on exosomal miR-21 inhibit programmed cell death 4 (PDCD4) in myocardial cells. The fruitful work provides a potential cell therapy strategy for myocardial ischemic diseases. RESULTS CPC-derived exosomes were collected and identified in morphology and phenotype The Sca-1+ cells isolated from adult mouse heart presented as long spindle-shaped fibrocyte-like adherent cells (Figure 1a). The percentage of Sca-1+ CPCs was determined with Flow Cytometry, and the results showed that up to 95.04±4.29% of population were Sca-1+ cells after magnetic-activated cell sorting (MACS; Figure 1b). To obtain the CPC-derived exosomes particles, the culture medium of CPCs was collected and precipitated. Then the morphology and phenotypes of isolated particles were identified according to the characteristics of exosomes described previously.16 First, the concentration and the range of size of the particles were measured using nanoparticle tracking analysis (Nanosight, Malvern, UK), the results demonstrated that the concentration of the particles was 1.31 × 109±0.29 × 109 particles per ml, and the diameters of the particles were within the range of 50–150 nm, with the average of 145 nm (Figure 1c). Secondly, the morphology of the CPC-derived particles was observed directly through transmission electron microscope (TEM), the particles were revealed as round-shaped vesicles with double layer membrane structure and diameters about 100 nm (Figure 1d). Finally, the protein levels of exosomes markers CD63, CD9 and Alix were measured with western blotting, all of the three markers could be detected in the CPC-derived exosomes (Figure 1e). So, the above properties analysis indicated that CPC-derived particles collected in our experiments were identified as exosomes. Oxidative stress enhanced the production of CPC-derived exosomes and caused apoptosis of cardiomyocytes To test the effects of oxidative stress on cardiac cells, CPCs and H9C2 (a cardiomyocyte cell line) were treated with H2O2. After treated with H2O2 on indicated concentrations for 6 h, the H9C2 cells were harvested for protein collection and western blotting. The results showed that 100 μM H2O2 increased the level of cleaved caspase-3 (the active type of caspase-3), suggesting an early apoptosis of the cardiomyocytes was induced under the oxidative stress (Figure 2a). Then, to observe whether the same condition of oxidative stress could affect the exosomes secretion of CPCs, exosomes were collected from CPCs treated with 100 μM H2O2 for 6 h, and exosomes' concentration was analyzed with nanoparticle trafficking analysis (NTA). The results showed that the exosomes concentrations increased from 1.31±0.29 × 109 particles per ml to 3.36±0.66 × 109 particles per ml after the H2O2 treatment, suggesting that the oxidative stress could enhance the exosomes production of CPCs (Figure 2b). MiR-21 in the CPC-derived exosomes increased under the oxidative stress, potentially was involved in protecting cardiomyocytes from apoptosis Exosome, acting as